PhRMA Says ‘Status Quo Must Change’ on Diabetes Prices

Drug Industry Daily
A A
PhRMA, pressed on all sides by critics of its members’ insulin-pricing policies, on Thursday made its public pitch to be part of the solution and not just the problem.

To View This Article:

Login

Subscribe To Drug Industry Daily